Apg Asset Management Us Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Apg Asset Management Us Inc.
- $14.6 Billion
- Q3 2024
A detailed history of Apg Asset Management Us Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Apg Asset Management Us Inc. holds 2,507 shares of REGN stock, worth $1.69 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,507
Previous 31,376
92.01%
Holding current value
$1.69 Million
Previous $33 Million
92.01%
% of portfolio
0.02%
Previous 0.19%
Shares
4 transactions
Others Institutions Holding REGN
# of Institutions
1,500Shares Held
83MCall Options Held
1.22MPut Options Held
1.5M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.27 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.68 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.04 Billion0.64% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.3 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$2.89 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $72.1B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...